Agios Pharmaceuticals, Inc. (AGIO)
Company Info
| ISIN | US00847X1046 |
|---|---|
| CUSIP | 00847X104 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $1.25B |
|---|---|
| EPS | -$3.94 |
| Revenue (TTM) | $24.03M |
| Gross Profit (TTM) | $12.54M |
| EBITDA (TTM) | -$377.35M |
| Year Range | $19.80 - $31.87 |
| Target Price | $38.00 |
| Short % | 10.25% |
| Short Ratio | 8.91 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Agios Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: AGIO vs. VEXMX, AGIO vs. MO, AGIO vs. PFE
Return
Agios Pharmaceuticals, Inc. had a return of -20.48% year-to-date (YTD) and -22.55% in the last 12 months. Over the past 10 years, Agios Pharmaceuticals, Inc. had an annualized return of 2.63%, while the S&P 500 had an annualized return of 9.74%, indicating that Agios Pharmaceuticals, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -20.48% | 18.75% |
| 1 month | 10.65% | 8.90% |
| 6 months | -13.52% | 8.42% |
| 1 year | -22.55% | 13.21% |
| 5 years (annualized) | -19.10% | 11.63% |
| 10 years (annualized) | 2.63% | 9.74% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -0.44% | 10.54% | 12.03% | -6.36% | 3.43% | -9.77% | -15.11% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
AGIO Agios Pharmaceuticals, Inc. | -0.59 | ||||
^GSPC S&P 500 | 0.98 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Agios Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Agios Pharmaceuticals, Inc. was 87.36%, occurring on Jun 14, 2022. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.36% | Jan 15, 2015 | 1866 | Jun 14, 2022 | — | — | — |
| -51.6% | Oct 7, 2013 | 36 | Nov 25, 2013 | 33 | Jan 14, 2014 | 69 |
| -38.02% | Jan 16, 2014 | 12 | Feb 3, 2014 | 23 | Mar 7, 2014 | 35 |
| -34.2% | Apr 10, 2014 | 28 | May 20, 2014 | 22 | Jun 20, 2014 | 50 |
| -32.91% | Jun 23, 2014 | 18 | Jul 17, 2014 | 48 | Sep 24, 2014 | 66 |
Volatility Chart
The current Agios Pharmaceuticals, Inc. volatility is 13.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.